Insulin resistance is usually treated with lifestyle changes first: weight loss when appropriate, regular exercise, higher-fiber eating patterns, better sleep, and management of related conditions such as prediabetes, PCOS, fatty liver, or high blood pressure. Some people may also benefit from clinician-prescribed medications, including metformin or GLP-1-based weight-loss treatment when medically appropriate.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does it mean to treat insulin resistance?
Insulin resistance means the body’s target tissues do not respond to insulin as strongly as expected; treatment means lowering that resistance and reducing the health risks tied to it. The goal is not a quick “detox.” It is a steady plan that improves blood sugar control, blood fats, blood pressure, liver health, and long-term metabolic risk over weeks to months.
Insulin helps move glucose from the blood into muscle and fat cells and helps signal the liver to reduce glucose output. In insulin resistance, insulin receptor signaling is weaker, so the pancreas may make more insulin, a state called hyperinsulinemia. Over time, this can contribute to prediabetes, type 2 diabetes mellitus, metabolic syndrome, hypertension, cardiovascular disease, polycystic ovary syndrome, and nonalcoholic fatty liver disease or nonalcoholic steatohepatitis 1, 2.
The drivers vary. For one person, the main issue may be visceral adiposity, inactivity, and sleep loss. For another, it may be PCOS, genetics, fatty liver disease, a medication that worsens glucose metabolism, or several factors at once. That is why a clinician should look for the cause, not just the label.
How insulin resistance affects muscle, liver, fat tissue, and blood sugar
In muscle, insulin resistance can reduce glucose uptake after meals. In the liver, it can allow more hepatic glucose production, which may raise fasting plasma glucose. In fat tissue, lipotoxicity, inflammation, lower adiponectin signaling, and mitochondrial dysfunction can make insulin signaling worse 1, 3.
Why insulin resistance is a risk factor, not a diagnosis to self-treat
Insulin resistance is a metabolic pattern. It is not something to diagnose from a symptom checklist alone. If you are trying to understand your risk, our guide to what insulin resistance is explains the basics, but lab testing and clinical context matter.
What are the warning signs of insulin resistance?
Warning signs of insulin resistance can include a larger waist size, high triglycerides, low HDL cholesterol, elevated blood pressure, prediabetes, fatty liver disease, PCOS, and acanthosis nigricans. Many people have no obvious symptoms, which is why labs are often needed.
Acanthosis nigricans means darker, thicker, velvety skin, often on the neck or body folds. It can be linked with insulin resistance, though other causes are possible. A 2026 clinical study evaluated a topical treatment for acanthosis nigricans, which shows that the skin finding is clinically studied, but it does not replace metabolic evaluation 4.
- Ask about testing if you have increased waist size, high triglycerides, low HDL cholesterol, high blood pressure, or a family history of type 2 diabetes.
- Ask about testing if you have PCOS symptoms, irregular periods, fatty liver disease, or prior gestational diabetes.
- Get prompt care if you have very high blood sugar symptoms such as extreme thirst, frequent urination, vomiting, confusion, or unexplained weight loss.
If you are unsure what to watch for, see our plain-language guide to signs of insulin resistance.
What tests can help check insulin resistance?
Testing for insulin resistance usually starts with risk markers, not one perfect test. Clinicians often use A1C, fasting glucose, lipids, blood pressure, waist circumference, and sometimes fasting insulin, HOMA-IR, or an oral glucose tolerance test; the research gold standard is the hyperinsulinemic-euglycemic clamp, but it is mainly used in studies, not routine visits 1, 5.
| Test or marker | What it can show | What to know |
|---|---|---|
| A1C | Average blood sugar over about 2–3 months | Helpful for prediabetes and diabetes screening; learn more in our A1C blood sugar test guide. |
| Fasting plasma glucose | Morning blood sugar after fasting | May be normal early in insulin resistance. |
| Oral glucose tolerance test | How the body handles a glucose load | May reveal impaired glucose handling that fasting glucose misses. |
| Fasting insulin and HOMA-IR | Insulin level or an insulin-resistance estimate | Useful in some settings, but not always routine or standardized. |
| Lipids, blood pressure, waist size, liver enzymes | Related metabolic risk | Helps look for metabolic syndrome, fatty liver risk, and cardiovascular risk. |
| Hyperinsulinemic-euglycemic clamp | Direct insulin sensitivity measurement | Mostly a research tool, not a typical clinic test. |
What is the fastest way to improve insulin resistance?
There is no safe instant fix for insulin resistance. The fastest evidence-based path is usually to combine regular movement, higher-quality calories, fiber, protein, sleep care, and weight loss when appropriate; some blood sugar markers may shift within weeks, while body composition and insulin sensitivity often take longer.
Exercise and dietary habit improvement are consistently described as central treatment strategies, while medications are considered for selected patients based on the underlying condition and risk level 1, 5. The practical goal is to reduce the demand for high insulin levels and improve how muscle, liver, and fat tissue respond to insulin.
- 1A clinician-guided plan may include moving most days, with both aerobic exercise and resistance training when safe.
- 2Nutrition guidance often focuses on meals built around high-fiber carbohydrates, protein, and unsaturated fats.
- 3Many plans aim to reduce sugar-sweetened drinks, refined starches, and ultra-processed snacks.
- 4Sleep care may be prioritized, including evaluation for sleep apnea risk if snoring, daytime sleepiness, or resistant high blood pressure is present.
- 5Related conditions such as PCOS, fatty liver disease, hypertension, and prediabetes should be treated with clinician guidance.
For a deeper step-by-step lifestyle discussion, see how to reduce or reverse insulin resistance.
Which foods help reduce insulin resistance?
Foods that help insulin resistance are usually foods that reduce glucose spikes, improve fullness, and support weight goals when needed. A Mediterranean-style pattern with high-fiber carbohydrates, lean proteins, unsaturated fats, and fewer refined foods is a practical starting point.
Good choices include beans, lentils, vegetables, oats, fruit, nuts, seeds, olive oil, fish, yogurt, eggs, and whole grains if tolerated. Pairing carbohydrates with protein and unsaturated fat can slow glucose rise after meals. This matters because insulin resistance is closely tied to glucose handling, liver metabolism, inflammation, and fat-cell signaling 1, 3.
Foods to limit include sugar-sweetened drinks, frequent sweets, refined starches, and ultra-processed snacks. Supplements and herbs need caution. A systematic review protocol on single herbal medicines for insulin resistance notes that evidence is still being evaluated and safety, product quality, interactions, and dosing vary 6.
What exercise is best for insulin resistance?
The best exercise for insulin resistance is the kind you can repeat safely: aerobic exercise plus resistance training. Muscle is a major glucose-using tissue, so building and using muscle can support glucose uptake over time 1, 5.
Aerobic exercise may improve how muscles use fuel. Resistance training helps preserve or build muscle, which supports glucose storage after meals. Reducing sedentary time also matters because long sitting periods reduce muscle activity and can worsen glucose handling 1, 5.
If you have obesity, joint pain, diabetes risk, chest pain, shortness of breath, neuropathy symptoms, or known heart disease, ask a clinician how to start safely. The right starting point may be walking, seated exercise, physical therapy, or a supervised plan rather than high-intensity workouts.
Which medications are used for insulin resistance?
Medications for insulin resistance depend on what is driving the problem. Metformin, a biguanide, is commonly discussed for prediabetes, type 2 diabetes risk, and PCOS-related metabolic issues; GLP-1 receptor agonists and dual incretin medicines may fit when weight management and metabolic risk overlap, but medication should be paired with lifestyle care, not used as a stand-alone fix 1, 5. Some uses discussed in insulin resistance, prediabetes, PCOS, or fatty-liver contexts may be off-label depending on the medication, formulation, and indication.
Metformin can cause stomach upset and is not right for everyone, especially people with certain kidney, liver, or alcohol-use risks. GLP-1 receptor agonists include liraglutide, semaglutide, and related medicines. Tirzepatide is a dual GIP/GLP-1 receptor agonist. These medicines can cause nausea, vomiting, diarrhea, constipation, gallbladder problems, and rare serious side effects; they also have contraindications and pregnancy considerations that require clinician review 7, 8.
Brand names can be confusing: liraglutide has been sold as Saxenda and Victoza; semaglutide has been sold as Ozempic, Wegovy, and Rybelsus; tirzepatide has been sold as Mounjaro and Zepbound. Compounded semaglutide via 503A pharmacy and compounded tirzepatide via 503A pharmacy are prescription options in some clinical settings, but compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
Human trial evidence also shows why underlying conditions matter. In the LEAN randomized trial, liraglutide was studied in adults with nonalcoholic steatohepatitis, a fatty-liver condition linked with insulin resistance 7. A 2026 post hoc analysis of the LAMP trial evaluated liraglutide outcomes by baseline insulin resistance status after stroke, showing that insulin resistance is used as a clinically relevant risk marker in human trials 8. Individual results vary.
| Situation | Sensible next step | Medication may fit when |
|---|---|---|
| A1C or fasting glucose is rising | Ask about prediabetes or diabetes testing and follow-up | Metformin or other glucose-focused care may be considered by a clinician. |
| Insulin resistance overlaps with excess adiposity | Combine nutrition, exercise, sleep, and weight-focused care | GLP-1-based treatment may be considered if benefits outweigh risks. |
| PCOS symptoms are present | Ask about PCOS evaluation, cycle history, androgen symptoms, and metabolic labs | Metformin or weight-focused medication may be discussed depending on goals and risks. |
| Fatty liver disease or high triglycerides are present | Ask about liver enzymes, imaging history, alcohol intake, and cardiometabolic risk | Medication choice depends on liver status, weight goals, diabetes risk, and side effects. |
| Herbs or supplements are being considered | Review product quality, interactions, and safety with a clinician | They should not replace evidence-based lifestyle or prescription care. |
3-min quiz
Considering weight-focused care?
If insulin resistance overlaps with weight-management goals, Chia can help you understand whether prescription treatment may be appropriate. We offer compounded semaglutide injection and compounded tirzepatide tablets or injection through licensed-provider review. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
Insulin resistance, weight loss, and GLP-1 treatment at Chia
Chia may fit when insulin resistance overlaps with weight-management goals and a licensed provider decides GLP-1-based care is appropriate. We do not diagnose insulin resistance from an article or promise a prescription; every plan starts with an online health questionnaire and clinician review, and dosing is provider-guided over time.
At Chia, semaglutide is available as a compounded injection, with plans currently starting at $249/mo and microdosing plans available when appropriate. Tirzepatide is available as compounded tablets or injection, with tablets currently starting at $249/mo and injections currently starting at $299/mo; microdosing plans are available when appropriate.
Chia also offers Weight + Energy, which includes NAD+ injection plus a choice of GLP-1, currently starting at $309/mo. Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Patients can message their care team through the patient portal between visits.
| Chia option | Forms listed in Chia’s catalog | Current starting price | Who it may fit |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | People seeking clinician-reviewed GLP-1 weight-management care when appropriate. |
| Tirzepatide | Tablets or injection | Tablets from $249/mo; injection from $299/mo | People who want to discuss a dual GIP/GLP-1 option and form preference with a provider. |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/mo | People whose goals include weight-focused care plus an energy-support protocol, if appropriate. |
Chia may not be the right path if you have suspected diabetes needing urgent care, pregnancy or breastfeeding considerations, complex endocrine disease, severe gastrointestinal disease, or symptoms that need in-person evaluation. In those cases, a primary care clinician, endocrinologist, OB-GYN, or urgent care setting may be a better first step.
Can insulin resistance go back to normal?
Insulin resistance can improve for many people, especially when the main drivers are weight gain, inactivity, poor sleep, or untreated metabolic risk factors. It can also return if those drivers return, so long-term follow-up matters more than a one-time lab result.
Progress can be tracked with A1C, fasting glucose, triglycerides, HDL cholesterol, blood pressure, waist measurement, weight trends, energy, menstrual regularity in PCOS, and liver markers when fatty liver disease is present. For weight-focused strategies, our guide to losing weight with insulin resistance explains why progress can be uneven.
What should you ask a clinician before starting treatment?
Before starting treatment, ask what condition is driving your insulin resistance and which markers should be followed. A good plan should cover benefits, side effects, contraindications, pregnancy considerations, follow-up, and what to do if symptoms change within the first few months.
- Do I have prediabetes, diabetes, PCOS, fatty liver disease, metabolic syndrome, or medication-related risk?
- Which labs should we check now, and how often should we repeat them?
- Would metformin, a GLP-1-based treatment, or another medication make sense for me?
- What side effects and contraindications should I know about?
- What changes should I make first: food, exercise, sleep, weight loss, or medication review?
- If I want to use supplements or herbs, what interactions or safety issues should we review?
If metformin is part of the discussion, our article on metformin for insulin resistance can help you prepare questions.
When should you get medical help now?
Get medical help now if you have symptoms of very high blood sugar, possible pregnancy with abnormal glucose, chest pain, fainting, severe dehydration, confusion, or unexplained weight loss. These are not situations to manage with online reading or a self-directed plan.
- Extreme thirst, frequent urination, vomiting, or confusion can signal dangerously high blood sugar.
- Chest pain, severe shortness of breath, or fainting needs urgent evaluation.
- Pregnancy, trying to conceive, or breastfeeding changes which tests and medications may be appropriate.
- New darkened skin changes, rapid weight change, irregular periods, or fatty-liver concerns should be discussed with a clinician.
3-min quiz
Start with a clinician-reviewed plan
If your main goal is weight-focused metabolic care, Chia’s online visit can help determine whether compounded semaglutide, compounded tirzepatide, or a related protocol may be appropriate. A licensed US provider reviews your health history and prescribes only when clinically appropriate; a prescription is not guaranteed.
FAQ
There is no safe instant fix. The fastest practical approach is usually a combined plan: regular movement, resistance training, higher-fiber meals, fewer sugar-sweetened drinks, sleep care, and weight loss when appropriate. Medication may help some people, but it should be clinician-guided.
Common clues include increased waist size, high triglycerides, low HDL cholesterol, elevated blood pressure, prediabetes, fatty liver disease, PCOS, and acanthosis nigricans. Many people have no clear symptoms, so testing is often needed.
No single food fixes insulin resistance. A helpful pattern often includes beans, lentils, vegetables, oats, fruit, whole grains, lean protein, nuts, seeds, olive oil, and fewer refined starches or sugary drinks.
It can improve for many people, especially when drivers such as excess visceral fat, inactivity, poor sleep, or untreated metabolic risk are addressed. It can also return if those drivers come back.
No. Insulin resistance means the body is less responsive to insulin. Prediabetes is a blood sugar category based on tests such as A1C, fasting glucose, or an oral glucose tolerance test. Insulin resistance can exist before prediabetes appears.
Weight loss can improve insulin sensitivity for many people with excess adiposity, especially visceral adiposity. It does not explain every case, and some people need evaluation for PCOS, medications, fatty liver disease, sleep apnea, genetics, or other conditions.
GLP-1-based medications are used for specific approved indications such as weight management or diabetes depending on the product, and they may improve metabolic risk partly through weight loss and glucose effects. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
Many people start without medication by changing food patterns, physical activity, sleep, and weight-related habits. Medication may be considered if blood sugar, weight-related risk, PCOS, fatty liver disease, or cardiovascular risk needs more support.
References
- 1.Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduction and Targeted Therapy. 2022.
- 2.Chen L, Chen R, Wang H, Liang F. The crucial role and mechanism of insulin resistance in metabolic disease. Frontiers in Endocrinology. 2023.
- 3.de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Letters. 2008.
- 4.Zafar K, Kabakova M, Bitterman D, et al. Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans. Journal of Drugs in Dermatology. 2026.
- 5.Wang Q, Jokelainen J, Auvinen J, et al. Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study. BMC Medicine. 2019.
- 6.Single Herbal Medicine for Insulin Resistance: protocol for a systematic review and meta-analysis. NIH PubMed Central. 2025.
- 7.Armstrong MJ, Gaunt P, Aithal GP, et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016.
- 8.Lu L, Yang B, Wang Y, et al. Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial. Stroke. 2026.
- 9.Van Laecke S, Caluwe R, Huybrechts I, et al. Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial. Annals of Transplantation. 2017.
- 10.Zein CO, Yerian LM, Gogate P, et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology. 2011.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



